Pharma tycoon Ge Li faces US class action case

Chairman of Genomics Medicine Ireland’s parent firm is defendant in share trading violation case

Ge Li, the founder of WuXi PharmaTech

The chairman of Genomics Medicine Ireland’s parent company is facing a class action lawsuit in the US over alleged violations of share trading rules.

Ge Li, the founder of WuXi PharmaTech is among a group of defendants being sued in New York for allegedly making “false and misleading statements” to the market in 2015 ahead of a merger which led to WuXi NextCode - Genomics Medicine Ireland’s parent company - being spun out ...